For an updated and complete list of publications, see:
Selection of recent publications from the lab
2023
Moreno E, et al. (2023) If You’re Not Confused, You’re Not Paying Attention: Ochrobactrum Is Not Brucella. Journal of Clinical Microbiology 61(8): e00438-23. doi: 10.1128/jcm.00438-23
Louche A, Blanco A, Lacerda TLS, Lionnet C, Bergé C, Rolando M, Lembo F, Borg4 JP, Buchrieser C, Nagahama M, Gorvel JP, Gueguen-Chaignon V, Terradot L, Salcedo SP (2023) The unique Brucella effectors NyxA and NyxB target SENP3 to modulate the subcellular localisation of nucleolar proteins. Nature Communications 14(1):102. doi: 10.1038/s41467-022-35763-8
Leukert L, Tietgen M, Krause FF, Schultze TG, Fuhrmann DC, Debruyne C, Salcedo SP, Visekruna A, Wittig L, Göttig S. (2023) Infection of Endothelial Cells with Acinetobacter baumannii Reveals Remodelling of Mitochondrial Protein Complexes. Microbiology Spectrum.11(3):e0517422. doi: 10.1128/spectrum.05174-22.
2021
Rubio T, Gagné S, Debruyne C, Dias C, Cluzel C, Mongellaz D, Rousselle P, Göttig S, Seifert H, Higgins PG, Salcedo SP (2021). Incidence of an intracellular multiplication niche amongst Acinetobacter baumannii clinical isolates. MSystems 7(1):e0048821. doi: 10.1128/msystems.00488-21
Luizet JB, Raymond J, Lacerda TLS, Barbieux E, Kambarev S, Bonici M, Lembo F, Willemart K, Borg JP, Celli J, Gérard FCA, Muraille E, Gorvel JP and Salcedo SP (2021) The Brucella effector BspL targets the ER-associated degradation (ERAD) pathway and delays bacterial egress from infected cells. Proc Natl Acad Sci USA 118(32):e2105324118. doi: 10.1073/pnas.2105324118
Roussin M and Salcedo SP (2021) NAD+-targeting by bacteria: an emerging weapon in pathogenesis. FEMS Microbiol Rev. fuab037. doi: 10.1093/femsre/fuab037
2020-2015
Coronas-Serna JM, Louche A, Rodríguez-Escudero M, Roussin M, Imbert PRC, Rodríguez-Escudero I, Molina M, Gorvel JP, Cid VJ*, Salcedo SP* (2020) The TIR-domain containing effectors BtpA and BtpB from Brucella abortus block energy metabolism. PLoS Pathogens 16(4):e1007979. doi: 10.1371/journal.ppat.1007979
Repizo GD, Viale AM, Borges V, Cameranesi MM, Taib N, Brochier C, Gomes JP and Salcedo SP (2017). The environmental Acinetobacter baumannii isolate DSM30011 reveals clues into the pre-antibiotic era genome diversity, virulence potential and niche range of a predominant nosocomial pathogen. Genome Biology and Evolution 9(9): 2292-2307. doi: 10.1093/gbe/evx162
Imbert PR, Louche A, Luizet JB, Granjean T, Bigot S, Wood TE, Gagné S, Blanco A, Wunderley L, Terradot L, Woodman P, Garvis S, Filloux A, Guery B and Salcedo SP. (2017) A Pseudomonas aeruginosaTIR effector mediates immune evasion by targeting UBAP1 and TLR adaptors. EMBO Journal. 36(13):1869-1887. https://doi.org/10.15252/embj.201695343
Patot S, Imbert PRC, Baude J, Martins Simões P, Campergue J-B, Louche A, Nijland R, Bès M, Tristan A, Laurent F, Fischer A, Schrenzel J, Vandenesch F, Salcedo SP, François P, Lina G (2016) The TIR Homologue Lies near Resistance Genes in Staphylococcus aureus, Coupling Modulation of Virulence and Antimicrobial Susceptibility. PLoS Pathog 12(12): e1006092. https://doi.org/10.1371/journal.ppat.1006092.
Repizo GD, Gagné S, Foucault-Grunenwald ML, Borges V, Charpentier X, Limansky AS, Gomes JP, Viale AM, Salcedo SP*. (2015) Differential Role of the T6SS in Acinetobacter baumannii PLoS One. 24;10(9):e0138265. https://doi.org/10.1371/journal.pone.0138265